Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
How Leadership Transition And Governance Debate At West Pharmaceutical (WST) Has Changed Its Investment Story
West Pharmaceutical Services (WST) reported strong Q4 2025 results and reaffirmed 2026 guidance amidst the impending retirement of its longtime CEO and Board Chair, Eric M. Green, in late 2026. This leadership transition and a shareholder proposal for an independent board chair introduce governance and succession timing as new watchpoints for investors, alongside the company’s existing focus on margin resilience. Despite the changes, management’s reaffirmed guidance signals confidence, but investors should be aware of potential execution risks during this period of leadership flux.